Literature DB >> 29367258

Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.

Anita K Nivedha1, Christofer S Tautermann1, Supriyo Bhattacharya1, Sangbae Lee1, Paola Casarosa1, Ines Kollak1, Tobias Kiechle1, Nagarajan Vaidehi2.   

Abstract

G-protein-coupled receptors (GPCRs) mediate multiple signaling pathways in the cell, depending on the agonist that activates the receptor and multiple cellular factors. Agonists that show higher potency to specific signaling pathways over others are known as "biased agonists" and have been shown to have better therapeutic index. Although biased agonists are desirable, their design poses several challenges to date. The number of assays to identify biased agonists seems expensive and tedious. Therefore, computational methods that can reliably calculate the possible bias of various ligands ahead of experiments and provide guidance, will be both cost and time effective. In this work, using the mechanism of allosteric communication from the extracellular region to the intracellular transducer protein coupling region in GPCRs, we have developed a computational method to calculate ligand bias ahead of experiments. We have validated the method for several β-arrestin-biased agonists in β2-adrenergic receptor (β2AR), serotonin receptors 5-HT1B and 5-HT2B and for G-protein-biased agonists in the κ-opioid receptor. Using this computational method, we also performed a blind prediction followed by experimental testing and showed that the agonist carmoterol is β-arrestin-biased in β2AR. Additionally, we have identified amino acid residues in the biased agonist binding site in both β2AR and κ-opioid receptors that are involved in potentiating the ligand bias. We call these residues functional hotspots, and they can be used to derive pharmacophores to design biased agonists in GPCRs.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29367258      PMCID: PMC5832328          DOI: 10.1124/mol.117.110395

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  31 in total

1.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

2.  Differences in allosteric communication pipelines in the inactive and active states of a GPCR.

Authors:  Supriyo Bhattacharya; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2014-07-15       Impact factor: 4.033

3.  A simple method for quantifying functional selectivity and agonist bias.

Authors:  Terry Kenakin; Christian Watson; Vanessa Muniz-Medina; Arthur Christopoulos; Steven Novick
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

Review 4.  Allosteric communication pipelines in G-protein-coupled receptors.

Authors:  Nagarajan Vaidehi; Supriyo Bhattacharya
Journal:  Curr Opin Pharmacol       Date:  2016-08-04       Impact factor: 5.547

5.  Conserved Mechanism of Conformational Stability and Dynamics in G-Protein-Coupled Receptors.

Authors:  Supriyo Bhattacharya; Romelia Salomon-Ferrer; Sangbae Lee; Nagarajan Vaidehi
Journal:  J Chem Theory Comput       Date:  2016-10-17       Impact factor: 6.006

6.  beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.

Authors:  Sudha K Shenoy; Matthew T Drake; Christopher D Nelson; Daniel A Houtz; Kunhong Xiao; Srinivasan Madabushi; Eric Reiter; Richard T Premont; Olivier Lichtarge; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2005-11-09       Impact factor: 5.157

7.  Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor.

Authors:  Nuska Tschammer; Stefan Bollinger; Terry Kenakin; Peter Gmeiner
Journal:  Mol Pharmacol       Date:  2010-12-16       Impact factor: 4.436

8.  The dynamic process of β(2)-adrenergic receptor activation.

Authors:  Rie Nygaard; Yaozhong Zou; Ron O Dror; Thomas J Mildorf; Daniel H Arlow; Aashish Manglik; Albert C Pan; Corey W Liu; Juan José Fung; Michael P Bokoch; Foon Sun Thian; Tong Sun Kobilka; David E Shaw; Luciano Mueller; R Scott Prosser; Brian K Kobilka
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.

Authors:  Tony Warne; Patricia C Edwards; Andrew G W Leslie; Christopher G Tate
Journal:  Structure       Date:  2012-05-09       Impact factor: 5.006

View more
  8 in total

Review 1.  Molecular Dynamics Simulation for All.

Authors:  Scott A Hollingsworth; Ron O Dror
Journal:  Neuron       Date:  2018-09-19       Impact factor: 17.173

2.  Novel M2 -selective, Gi -biased agonists of muscarinic acetylcholine receptors.

Authors:  Alena Randáková; Dominik Nelic; Dana Ungerová; Peter Nwokoye; Qiwen Su; Vladimír Doležal; Esam E El-Fakahany; John Boulos; Jan Jakubík
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

3.  Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin Interaction.

Authors:  Michael Ippolito; Francesco De Pascali; Asuka Inoue; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2021-12-01       Impact factor: 4.436

4.  Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom's Alkaloids with Reported Antinociception In Vivo.

Authors:  Yuchen Zhou; Steven Ramsey; Davide Provasi; Amal El Daibani; Kevin Appourchaux; Soumen Chakraborty; Abhijeet Kapoor; Tao Che; Susruta Majumdar; Marta Filizola
Journal:  Biochemistry       Date:  2020-12-04       Impact factor: 3.162

Review 5.  How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.

Authors:  Mariona Torrens-Fontanals; Tomasz Maciej Stepniewski; David Aranda-García; Adrián Morales-Pastor; Brian Medel-Lacruz; Jana Selent
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

6.  Activation mechanism of the class D fungal GPCR dimer Ste2.

Authors:  Vaithish Velazhahan; Ning Ma; Nagarajan Vaidehi; Christopher G Tate
Journal:  Nature       Date:  2022-03-16       Impact factor: 69.504

Review 7.  In Silico Study of Allosteric Communication Networks in GPCR Signaling Bias.

Authors:  Adrian Morales-Pastor; Francho Nerín-Fonz; David Aranda-García; Miguel Dieguez-Eceolaza; Brian Medel-Lacruz; Mariona Torrens-Fontanals; Alejandro Peralta-García; Jana Selent
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

Review 8.  Deep learning approaches for conformational flexibility and switching properties in protein design.

Authors:  Lucas S P Rudden; Mahdi Hijazi; Patrick Barth
Journal:  Front Mol Biosci       Date:  2022-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.